A leading neuroscience research and development company initiated a USD 32 million project to upgrade their drug production plant in Durham, North Carolina, to increase manufacturing capacity of an innovative drug that furthers Alzheimer’s disease therapies. To allow for renovations and equipment installation that would accommodate simultaneous filtration cycles of the new drug, the firm needed to implement a three-month plant shutdown. They hired DPR Construction as the contractor for the biopharmaceutical, manufacturing project, which included debottlenecking one of the plant’s purification suites and creating additional upstream modifications.

Join for free to read